BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu Q, Che G, Yang Y, Xie H, Tian J. Histone Deacetylase 3 Aggravates Type 1 Diabetes Mellitus by Inhibiting Lymphocyte Apoptosis Through the microRNA-296-5p/Bcl-xl Axis. Front Genet 2020;11:536854. [PMID: 33240312 DOI: 10.3389/fgene.2020.536854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Che S, Wu S, Yu P. Downregulated HDAC3 or up-regulated microRNA-296-5p alleviates diabetic retinopathy in a mouse model. Regenerative Therapy 2022;21:1-8. [DOI: 10.1016/j.reth.2022.04.002] [Reference Citation Analysis]
2 Sonthalia M, Roy BS, Chandrawanshi D, Ganesh GV, Jayasuriya R, Mohandas S, Rajagopal S, Ramkumar KM. Histone deacetylase inhibitors as antidiabetic agents: Advances and opportunities. European Journal of Pharmacology 2022;935:175328. [DOI: 10.1016/j.ejphar.2022.175328] [Reference Citation Analysis]
3 Li P, Ren X, Zheng Y, Sun J, Ye G. Tumor promoting effect of circ_002172 associates with induced immune escape in breast cancer via the miR-296-5p/CXCL12 axis. Int Immunopharmacol 2022;106:108530. [PMID: 35240495 DOI: 10.1016/j.intimp.2022.108530] [Reference Citation Analysis]
4 Ning L, Rui X, Bo W, Qing G. The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury. Cell Death Dis 2021;12:734. [PMID: 34301918 DOI: 10.1038/s41419-021-04019-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Alcazar O, Hernandez LF, Nakayasu ES, Nicora CD, Ansong C, Muehlbauer MJ, Bain JR, Myer CJ, Bhattacharya SK, Buchwald P, Abdulreda MH. Parallel Multi-Omics in High-Risk Subjects for the Identification of Integrated Biomarker Signatures of Type 1 Diabetes. Biomolecules 2021;11:383. [PMID: 33806609 DOI: 10.3390/biom11030383] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]